← FDA DRUG APPROVALS

FDA ANDA · ANDA040138

ESTRADIOL

Sponsor: LANNETT CO INC

APPLICATION
ANDA040138
TYPE
ANDA
ORIGINAL APPROVAL
1998-01-30
LATEST ACTION
2000-12-21
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

ESTRADIOLDiscontinued
ESTRADIOL 1MG · TABLET · ORAL
ESTRADIOLDiscontinued
ESTRADIOL 2MG · TABLET · ORAL
ESTRADIOLDiscontinued
ESTRADIOL 0.5MG · TABLET · ORAL

Approval history

2000-12-21Manufacturing (CMC) · Supplement 3AP
2000-12-21Manufacturing (CMC) · Supplement 2AP
2000-09-08Labeling · Supplement 4AP
1998-01-30OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →